Inside the Lemonaid Health Buy: Kyle Pretsch on Bambu Ventures’s Bold Play
Bambu Ventures's Kyle Pretsch dives into Lemonaid’s $10M buyout, down from 23andMe’s $400M price tag, and what’s next after Chrome Co.’s dramatic pivot.
More Videos
Frozen Yogurt Was Supposed to Be Over, Gen Z Had Other Plans
16 Handles CEO Neil Hershman explains why Gen Z is fueling frozen yogurt’s comeback and how the brand plans to stay ahead as competition heats up.
Rocket Lab’s Next Giant Leap: Building an End-to-End Space Company
Rocket Lab CEO Peter Beck on the company’s record growth, Neutron, its Iridium deal, defense ambitions and the race to build a space powerhouse.
Helion Is Betting Big on Fusion: Here’s What Comes Next
Helion CEO David Kirtley on the company’s push to deliver commercial fusion by 2028 and meet soaring demand for clean, reliable electricity.
The Oil Market’s Next Big Test: War, Inflation and the Midterms
Rob Schroeder, Washington Bureau Chief at MarketWatch, breaks down oil prices, inflation, energy policy and the road to the midterm elections.
The New Complex: AI, Sports, Shopping and the Business of Culture
Complex President Moksha Fitzgibbons explains how the brand is blending media, AI, e-commerce, sports & live experiences to build a new kind of culture business
Stocks Keep Climbing Despite Macro Headwinds: What’s Driving the Rally?
Bret Kenwell, eToro’s U.S. Investment and Options Analyst, explains what’s driving stocks higher and whether the market rally has room to run.
